Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer
Ashley M. Henneghan(The University of Texas at Austin), Shelli R. Kesler(Livestrong Foundation), Oxana Palesh(Virginia Commonwealth University), Vikram Rao(The University of Texas MD Anderson Cancer Center), Douglas W. Blayney(Stanford University), Rebecca A. Harrison(BC Cancer Agency), Meghan Karuturi(The University of Texas MD Anderson Cancer Center)
Cited by 39
Related Papers
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
|Journal of Clinical Oncology|2015|903
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
|Journal of Clinical Oncology|2016|654
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group
|JNCI Journal of the National Cancer Institute|2021|115
Cognitive Impairment in Non-critical, Mild-to-Moderate COVID-19 Survivors
|Frontiers in Psychology|2022|87